Angela Spivey and Sam Jockel comment on anticipated Food and Drug Administration priorities under the Biden administration, including increased oversight of supplements and a renewed focus on cannabidiol.
In the News
June 30, 2021
HBW Insight, Rose Sheet | US FDA Priorities for Food Safety, Cannabidiod Clear Even with Next Commissioner Unknown
Related News & Insights
-
Look Ahead February 14, 2022Look Ahead to the Week of February 14: The Senate Moves to Pass the Continuing ResolutionThe House has no votes scheduled this week, but the Senate must pass a continuing resolution before Friday to prevent a government shutdown. The upper chamber will also vote on more of President Biden’s nominees and a package of changes to the U.S. Postal Service.
-
Medical Products Supply Chain Week in Review January 31, 2022FDA extends pause on non-mission-critical domestic surveillance inspections to February 4 – Medical Products Supply Chain Week in ReviewOSHA withdrew its emergency temporary standard, which required a mandatory vaccination policy for large private employers. The FDA extended its pause on non-mission-critical domestic surveillance inspections to February 4, and the Biden Administration announced that it was making at-home test kits available to the American public. Robert Califf previewed his priorities, if confirmed as commissioner of the FDA, to the Senate HELP Committee. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.
-
Medical Products Supply Chain Week in Review November 12, 2021Medical Products Supply Chain Week in Review – November 11, 2021In the past week, the President has selected Dr. Robert Califf to be FDA commissioner. Congress passed the Infrastructure Investment and Jobs Act. New vaccination requirements were issued by OSHA and CMS for certain employers. Also, the State Department updated its rules for passengers entering the United States. Please see details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.
-
In the News November 11, 2021The Pink Sheet | Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite LightlyMarc Scheineson comments on President Biden’s nomination of Robert for a second term as commissioner of the U.S. Food and Drug Administration.
-
Medical Products Supply Chain Week in Review October 28, 2021Medical Products Supply Chain Week in Review – October 28, 2021In the past week, the FDA Vaccines and Related Biological Products Advisory Committee recommended authorization of the Pfizer-BioNTech vaccine for use in children 5–11 years of age. The CDC formally endorsed the booster dose for the Moderna and J&J vaccines. President Biden met with Dr. Robert Califf for the top FDA post. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.
Media Contact